Don’t see your
company? Let’s change
that.
company? Let’s change
that.
Don't see your company?
Create a company profileAdvNanoT is based on biodegradable nanoparticles (NP) specifically designed to have higher vascular uptake and cellular retention. We are developing novel Sirolimus-based medical devices to treat atherosclerosis and blockage for Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD).
Work Your Passion. Live Your Purpose.